Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy

被引：0

作者：

Hazim, A. ^{[1
]}

Xiao, A. ^{[1
]}

Singh, A. ^{[1
]}

Chung, K. ^{[2
]}

dos Santos, P. A. Reck ^{[2
]}

D'Cunha, J. ^{[2
]}

Shanshal, M. ^{[1
]}

Dimou, A. ^{[1
]}

Parikh, K. ^{[1
]}

Lou, Y. ^{[3
]}

Manochakian, R. ^{[3
]}

Leventakos, K. ^{[1
]}

Molina, J. ^{[1
]}

Mansfield, A. ^{[1
]}

Ernani, V. ^{[2
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Mayo Clin, Scottsdale, AZ USA

[3] Mayo Clin, Jacksonville, FL 32224 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

chemoimmunotherapy; neoadjuvant; non small cell lung cancer;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP.07C.16

引用

页码：S546 / S547

页数：2

共 50 条

[41] Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer
Jacob Y. Shin
Ja Kyoung Yoon
Gaurav Marwaha
Lung, 2018, 196 : 351 - 358
[42] Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
Broderick, Stephen R.
Bott, Matthew J.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (05): : 1471 - 1474
[43] Discussion to: Early real-world experience monitoring circulating tumor DNA in resected early-stage non-small cell lung cancer
Martin, Travis K.
Sachdeva, Uma
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (05): : 1360 - 1361
[44] Adjuvant immunotherapy in early-stage resectable non-small cell lung cancer: A new milestone
Tang, Wen-Fang
Ye, Hong-Yu
Tang, Xuan
Su, Jian-Wei
Xu, Kang-Mei
Zhong, Wen-Zhao
Liang, Yi
FRONTIERS IN ONCOLOGY, 2023, 13
[45] INCREASED REAL-WORLD BIOMARKER TEST UTILIZATION IN PATIENTS WITH EARLY-STAGE NON-SMALL CELL LUNG CANCER IN THE UNITED STATES, 2011 TO 2021
Yan, J.
Jin, Y.
Lo, E.
Chen, Y.
Hanlon, Newell Ae
Kong, Y.
Inge, L.
VALUE IN HEALTH, 2023, 26 (06) : S306 - S306
[46] Real-world outcomes for patients with inoperable stage III non-small cell lung cancer: a prognostic role for albumin?
Leach, James
Stares, Mark
Langley, Benjamin
Fenner, Florence
Killean, Angus
Barrie, Colin
Maclennan, Kirsty
Campbell, Sorcha
Evans, Tamasin
Tufail, Aisha
Harrow, Stephen
McMenemy, Maria
Mackean, Melanie
Phillips, Iain
LUNG CANCER, 2022, 165 : S58 - S58
[47] Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study
Cheema, Parneet K.
Syed, Iqra
Gwadry-Sridhar, Femida
Rakibuz-Zaman, Muhammad
Sachdeva, Robin
Pencz, Alec
Zhan, Luna
Hueniken, Katrina
Patel, Devalben
Balaratnam, Karmugi
Khan, Khaleeq
Grant, Benjamin
Sheffield, Brandon S.
Locke, M. Elizabeth O.
Moldaver, Daniel
Shanahan, Mary Kate
Liu, Geoffrey
Kuruvilla, M. Sara
CURRENT ONCOLOGY, 2024, 31 (11) : 6735 - 6748
[48] Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada
Yusuf, Dimas
Ko, Jenny J.
Cho, Hyokeun
Sheremeto, Corey
Wang, Ying
Juergens, Rosalyn A.
Ellis, Peter Michael
Billawala, Alkarim
Kay, Amin
Kulkarni, Swati
Elfiki, Tarek A.
Gupta, Rasna
Naccarato, Krista
Pennetti, Alex
Patel, Devalben
Smith, Elliot Charles
Walton, Ryan
Hurry, Manjusha
Liu, Geoffrey
Cheung, Winson Y.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
[49] Osimertinib as Neoadjuvant Therapy for Resectable EGFR Mutant Non-small Cell Lung Cancer: A Real-World Multicenter Retrospective Study
Leng, X.
Tang, J.
Wang, S.
Wang, Y.
Li, P.
Wang, S.
Wei, X.
Peng, L.
Fang, Q.
Han, Y.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S979 - S979
[50] Early stage resectable non-small cell lung cancer: is neoadjuvant immunotherapy the right way forward?
Chiari, Rita
Sidoni, Angelo
Metro, Giulio
JOURNAL OF THORACIC DISEASE, 2018, 10 : S3890 - S3894

← 1 2 3 4 5 →